Bentley’s BeBack Catheter Launched in the United States

May 17, 2023—Bentley InnoMed GmbH, headquartered in Hechingen, Germany, announced the United States launch of the BeBack crossing catheter, which is designed for the treatment of heavily calcified lesions.

BeBack is the company’s first product to be launched in the United States. In addition to FDA clearance, the BeBack device has received CE Mark approval. Bentley introduced the device outside the United States in January 2023.

In September 2022, Bentley announced the acquisition of the GoBack catheter from Israel-based Upstream Peripheral Technologies. Upstream initially launched the device in 2019. It was available in 23 countries. After the acquisition, GoBack was rebranded as the BeBack to benefit from Bentley’s corporate branding and product synergies, noted the company.

According to Bentley, the BeBack catheter is designed for steering through chronic total occlusions (CTO), which are often the most challenging part when treating heavily calcified lesions.

The catheter is available in an 80- and 120-cm catheter in both a 2.9 and 4 F sizes. The device features a steerable nitinol needle that is adjustable in length, which is used for crossing and targeted re-entry. The curved needle is located near the tip of the catheter. A radiopaque marker indicates the direction the needle protrudes. Multiple treatment options including antegrade, retrograde, and crossover are possible with the BeBack crossing catheter for intraluminal and subintimal approaches of stenotic or occluded lesions, stated the company.

Robert E. Beasley, MD, a vascular and interventional radiologist at Palm Vascular Centers in Miami Beach, Florida, performed the first procedure in the United States with the BeBack device.

“Now that the BeBack is available, I use it more frequently compared to other re-entry devices that are available on the market,” commented Dr. Beasley in Bentley’s press release. “The unique features of the BeBack make the most complex lesions easy to cross, and therefore the device helps to reduce the procedure time. “Reducing the procedure time is of huge benefit for the clinical center, the physician, and, of course, for the patients, who will benefit the most. This and the unique features make the BeBack such a game changer for CTO procedures.”